Analysis by Winter Mead, vice-president, Sapphire Ventures

Cancer therapy developer G1 Therapeutics has gone public in an initial public offering that gave an exit to long-time investor MedImmune Ventures.

The reverse merger with Nasdaq-listed Mirna, which counts Pfizer and Baxter as backers, was agreed alongside the disclosure of a $42m series C round.

HTGF has backed a series A round for Cardior Pharmaceuticals, a heart failure-focused spinout of Hannover Medical School.

Bruker has acquired Luxendo, a spinout of the European Molecular Biology Laboratory that closed an $8.4m series A round in January.

Boehringer Ingelheim and Bristol-Myers Squibb have backed a series A round for Cardior Pharmaceuticals, a heart failure-focused spinout of Hannover Medical School.

Novo has contributed to a series A round for Genoa Pharmaceuticals, which is aiming to get its IPF treatment into clinical trials this year.